Ondansetron

Prescription ·Strong evidence ·Reviewed May 2026

A selective serotonin 5-HT3 receptor antagonist used for the prevention and treatment of nausea and vomiting caused by chemotherapy, radiation therapy, and surgery. Ondansetron is one of the most widely prescribed antiemetics and is also commonly used off-label for acute gastroenteritis-related nausea.

What it's good for
  • Prevention of chemotherapy-induced nausea and vomiting10,6
  • Prevention of radiation-induced nausea and vomiting10,6
  • Prevention of postoperative nausea and vomiting10
  • Off-label: acute gastroenteritis nausea9,10
What to watch for
  • Headache
  • Constipation
  • Dizziness
  • Known hypersensitivity to ondansetron or other 5-HT3 antagonists1,2
  • Concurrent use with apomorphine (risk of severe hypotension)4

The bottom line

Evidence rating strong. Most-documented uses: prevention of chemotherapy-induced nausea and vomiting, prevention of radiation-induced nausea and vomiting, prevention of postoperative nausea and vomiting. 10 sources indexed (2014–2023), with 3 interaction records on file.

The science

How it works, mechanistically.

Core mechanism

Selectively blocks serotonin (5-hydroxytryptamine, 5-HT3) receptors both peripherally on vagal nerve terminals in the GI tract and centrally in the chemoreceptor trigger zone (CTZ) of the area postrema. By blocking 5-HT3 receptors, ondansetron prevents the initiation of the vomiting reflex triggered by serotonin release from enterochromaffin cells.

Class
Antiemetic (5-HT3 Antagonist)
Dosing

Dosing & protocol.

Common range
4–8 mg every 8 hours as needed; up to 24 mg for highly emetogenic chemotherapy (as prescribed by your physician)
Recommended form
Oral tablet, orally disintegrating tablet (ODT), or IV injection

Can be taken with or without food; ODT dissolves on tongue without water

Safety

Full safety detail.

Side effects

  • Headache
  • Constipation
  • Dizziness
  • Fatigue
  • QT prolongation (dose-dependent)
  • Injection site reactions (IV form)

Contraindications

  • Known hypersensitivity to ondansetron or other 5-HT3 antagonists1,2
  • Concurrent use with apomorphine (risk of severe hypotension)4
  • Congenital long QT syndrome
  • Caution with other QT-prolonging medications
  • Severe hepatic impairment (maximum 8 mg/day)
Interactions

Interaction records.

InfoSynergy

Ginger Extract

Ginger has randomized-trial and meta-analysis evidence as an adjunct to standard antiemetic regimens for chemotherapy-induced nausea and vomiting. Many standard regimens include 5-HT3 antagonists such as ondansetron, so ginger may reduce nausea burden without replacing prescription antiemetics. Benefits are strongest for nausea outcomes and vary by dose and formulation.

Recommendation: If ondansetron alone is not controlling nausea, ginger extract can be considered as an adjunct with meals. Use standardized doses and avoid high-dose ginger if you are on anticoagulants, have a bleeding disorder, or are preparing for surgery. Seek care if vomiting prevents fluids or medications from staying down.

SeriousCaution

Magnesium Glycinate

Ondansetron can prolong the QT interval and rare cases of torsades de pointes have been reported, especially with IV dosing or predisposing risks. Low magnesium is a known risk factor for drug-induced long QT and torsades. Maintaining normal magnesium status lowers this background risk, particularly during vomiting, diarrhea, diuretic use, or poor intake.

Recommendation: Do not take high-dose magnesium without medical advice, but maintain normal magnesium intake while using ondansetron if you have ongoing GI losses or QT-risk factors. Ask about checking electrolytes if you need repeated ondansetron doses, have heart disease, take other QT-prolonging drugs, or have severe vomiting or diarrhea. Seek urgent care for fainting, palpitations, or seizure-like episodes.

SeriousCaution

Potassium

Ondansetron can prolong QT interval, and hypokalemia makes drug-induced torsades de pointes more likely. Vomiting and diarrhea can lower potassium at the same time ondansetron is being used, creating a clinically important risk cluster. Keeping potassium normal is protective, but inappropriate potassium supplementation can be dangerous.

Recommendation: Do not start potassium supplements unless your clinician recommends them, especially if you have kidney disease or take ACE inhibitors, ARBs, or potassium-sparing diuretics. Ask about electrolyte checks if you have prolonged vomiting, diarrhea, repeated ondansetron dosing, heart disease, or other QT-prolonging drugs. Seek urgent care for fainting, severe weakness, palpitations, or confusion.

Sources

Sources, by evidence tier.

Numbered references. Citations throughout the page link here.

Meta-analyses & systematic reviews

7
Keep exploring

Deep dives & adjacent profiles.

This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.

Use this with your stack

Ondansetron in NutriStack.

Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.